ASCO Living Guideline | Therapy for stage IV non–small-cell lung cancer with driver alterations.
12 Jul, 2022 | 12:46h | UTC
Commentary on Twitter
Just published in #JCO: ? Updated recommendations on therapy for stage IV #NSCLC with driver alterations by @ns_chd et al ? https://t.co/JzrxEey4Si #lungcancer #lcsm pic.twitter.com/CFPTJIkrhK
— Journal of Clinical Oncology (@JCO_ASCO) July 11, 2022